EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Antidepressants and the endogenous opioid system

Lloyd D Fricker, Aya Osman, Achla Gupta, Ivone Gomes, Lakshmi A Devi

Biochemical Pharmacology · 2025

DOI: 10.1016/j.bcp.2025.117392 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2025. Verfasst von Lloyd D Fricker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA; Department of Pharmacological …. Hauptthemen laut MEDLINE: Antidepressive Agents, Receptors, Opioid, Opioid Peptides, Analgesics, Opioid. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Brain and Behavior Research Foundation, National Institutes of Health Center for Scientific Review.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endogenous opioid system consists of three different G protein-coupled receptors, named mu-, delta- and kappa-opioid receptors (MOR, DOR, and KOR, respectively). These receptors are activated by over 20 distinct peptides produced from proenkephalin, prodynorphin, and proopiomelanocortin. The endogenous opioid system contributes to many important functions including analgesia, reward, and regulation of mood. A growing body of evidence links the opioid system with major depressive disorder. One strong line of evidence is that two different widely used antidepressants, tianeptine and ketamine, both interact with MOR; tianeptine as a full agonist, and ketamine as a positive allosteric modulator. Both of these drugs produce clinical antidepressant effects within hours or days. Buprenorphine, a partial MOR agonist commonly used for treating opioid use disorder, also shows promise as a rapid-acting antidepressant. While the conventional view is that major depressive disorder is caused by an imbalance of biogenic amine neurotransmitters, drugs that affect these neurotransmitter systems typically require weeks of dosing before showing antidepressant effects. Chronic antidepressant treatment of mice causes changes in gene expression. Interestingly, proenkephalin is one of the most highly upregulated genes following long-term treatment of mice with fluoxetine, a selective serotonin reuptake inhibitor. Taken together, these findings suggest that the opioid system plays an important role in major depressive disorder. In this review, we discuss the strengths, problems, and limitations of the studies, as well as areas in need of further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antidepressive AgentsReceptors, OpioidOpioid PeptidesAnalgesics, OpioidAnimalsHumansMajor Depressive Disorder

Stichwörter der Autor:innen

EndorphinFluoxetineKetamineMajor depressive disorderOpioid receptorProenkephalinTianeptine

Substanzen

Antidepressive AgentsReceptors, OpioidOpioid PeptidesAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy P…
  • Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA; Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, 1 Gusta…
  • Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA.

Förderung

  • NIDA NIH HHS
  • Brain and Behavior Research Foundation
  • National Institutes of Health Center for Scientific Review

Zitieren

APA

Fricker, L. D., Osman, A., Gupta, A., Gomes, I., & Devi, L. A. (2025). Antidepressants and the endogenous opioid system. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117392

Vancouver

Fricker LD, Osman A, Gupta A, Gomes I, Devi LA. Antidepressants and the endogenous opioid system. Biochemical Pharmacology. 2025. doi:10.1016/j.bcp.2025.117392

BibTeX
@article{Fricker2025,
  author = {Fricker, Lloyd D and Osman, Aya and Gupta, Achla and Gomes, Ivone and Devi, Lakshmi A},
  title = {Antidepressants and the endogenous opioid system},
  journal = {Biochemical Pharmacology},
  year = {2025},
  doi = {10.1016/j.bcp.2025.117392}
}
Kostenlos starten →